1. Zhang CY, Cai X, Guo L, Wang L, Liu Z, Luo XJ, Li M, GeseDNA Research Team, Wang C, Li T, Xiao X. Genetic evidence for the "dopamine hypothesis of bipolar disorder". Molecular Psychiatry 2022. doi: 10.1038/s41380-022-01808-z.
2. Xiao X, Zhang CY, Zhang Z, Hu Z, Li M, Li T. Revisiting tandem repeats in psychiatric disorders from perspectives of genetics, physiology, and brain evolution. Molecular Psychiatry 2022;27:466-475.
3. Chang H, Cai X, Li HJ, Liu WP, Zhao LJ, Zhang CY, Wang JY, Liu JW, Ma XL, Wang L, Yao YG, Luo XJ, Li M, Xiao X. Functional genomics identify a regulatory risk variation rs4420550 in the 16p11.2 schizophrenia-associated locus. Biological Psychiatry 2021;89:246-255. (Cover story)
4. Zhang C, Xiao X, Li T, Li M. Translational genomics and beyond in bipolar disorder. Molecular Psychiatry 2021;26:186-202.
5. Jun-Yang Wang, Xiao-Yan Li, Hui-Juan Li, Jie-Wei Liu, Yong-Gang Yao, Ming Li, Xiao Xiao, Xiong-Jian Luo. Integrative analyses followed by functional characterization reveal TMEM180 as a schizophrenia risk gene. Schizophrenia Bulletin 2021;47:1364-1374.
6. Yang Z, Zhou D, Li H, Cai X, Liu W, Wang L, Chang H, Li M, Xiao X. The genome-wide risk alleles for psychiatric disorders at 3p21.1 show convergent effects on mRNA expression, cognitive function and mushroom dendritic spine. Molecular Psychiatry 2020;25:48-66.
7. Li H, Zhang C, Cai X, Wang L, Luo F, Ma Y, Li M, Xiao X. Genome-wide association study of creativity reveals genetic overlap with psychiatric disorders, risk tolerance, and risky behaviors. Schizophrenia Bulletin 2020;46:1317-1326.
8. Liu W, Li W, Cai X, Yang Z, Li H, Su X, Song M, Zhou DS, Li X, Zhang C, Shao M, Zhang L, Yang Y, Zhang Y, Zhao J, Chang H, Yao YG, Fang Y, Lv L, Li M, Xiao X. Identification of a functional human-unique 351-bp Alu insertion polymorphism associated with major depressive disorder in the 1p31.1 GWAS risk loci. Neuropsychopharmacology 2020;45:1196-1206.
9. Li HJ, Su X, Zhang L, Zhang CY, Wang L, Li W, Yang Y, Lv L, Li M, Xiao X. Transcriptomic analyses of humans and mice provide insights into depression. Zoological Research 2020;41:632-643.
10. Li H, Chang H, Song X, Liu W, Li L, Wang L, Yang Y, Zhang L, Li W, Zhang Y, Zhou DS, Li X, Zhang C, Fang Y, Sun Y, Dai JP, Luo XJ, Yao YG, Xiao X, Lv L, Li M. Integrative analyses of major histocompatibility complex loci in the genome-wide association studies of major depressive disorder. Neuropsychopharmacology 2019;44:1552-1561.
11. Weipeng Liu, Hao Yan, Danyang Zhou, Xin Cai, Yuyanan Zhang, Shiyi Li, Huijuan Li, Shiwu Li, Dong-Sheng Zhou, Xingxing Li, Chen Zhang, Yan Sun, Jia-Pei Dai, Jingmei Zhong, Yong-Gang Yao, Xiong-Jian Luo, Yiru Fang, Dai Zhang, Yina Ma, Weihua Yue, Ming Li, Xiao Xiao. The depression GWAS risk allele predicts smaller cerebellar gray matter volume and reduced SIRT1 mRNA expression in Chinese population. Translational Psychiatry 2019; 9:333.
12. Xiao X, Zhang C, Grigoroiu-Serbanescu M, Wang L, Li L, Zhou D, Yuan T-F, Wang C, Chang H, Wu Y, Li Y, Wu D-D, Yao Y-G, Li M. The cAMP responsive element-binding (CREB)-1 gene increases risk of major psychiatric disorders. Molecular Psychiatry 2018;23:1957-1967.
13. Xiao X, Zheng F, Chang H, Ma Y, Yao YG, Luo XJ, Li M. The gene encoding protocadherin 9 (PCDH9), a novel risk factor for major depressive disorder. Neuropsychopharmacology 2018;43:1128-1137.